Data / Form D filings / Evogene Ltd.
Evogene Ltd.: Form D filings
Evogene Ltd., a pharmaceuticals company in Rehovot, Israel, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on February 19, 2026, reports $3.4 million sold of a $3.4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 13 GAD FEINSTEIN STREET PARK REHOVOT, Rehovot, Israel, 76385
- Phone
- 97289311900
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1574565
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | New notice | $3,384,616 | $3,384,616 | 1 | Feb 11, 2026 | sec.gov | |
| Sep 4, 2024 | New notice | $12,015,387 | $0 | $12,015,387 | 1 | Aug 23, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ofer Haviv | Executive Officer, Director | President and Chief Executive Officer and Director |
| Yaron Eldad | Executive Officer | Chief Financial Officer |
| Gabi Tarcic | Executive Officer | Vice President Product |
| Ilia Zhidkov | Executive Officer | Vice President Computational Platform |
| Nir Nimrodi | Director | Chairperson of the Board |
| Sarit Firon | Director | |
| Dan Falk | Director | |
| Adrian Percy | Director | |
| Leon Yehuda Recanati | Director |
Every Form D from the week of Feb 16, 2026 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Evogene Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.